{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:29:49Z","timestamp":1794331789469,"version":"4.9.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL139561"],"award-info":[{"award-number":["HL139561"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.yexcr.2019.04.029","type":"journal-article","created":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T20:01:56Z","timestamp":1556395316000},"page":"180-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Epoxyeicosatrienoic intervention improves NAFLD in leptin receptor deficient mice by an increase in HO-1-PGC1\u03b1 mitochondrial signaling"],"prefix":"10.1016","volume":"380","author":[{"given":"Marco","family":"Raffaele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Favero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Rezzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi Fabrizio","family":"Rodella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Falck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader G.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Vanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2019.04.029_bib1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4254\/wjh.v9.i16.715","article-title":"Non-alcoholic fatty liver disease: an expanded review","volume":"9","author":"Benedict","year":"2017","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.yexcr.2019.04.029_bib2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","article-title":"Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?","volume":"68","author":"Lonardo","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.yexcr.2019.04.029_bib3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.21037\/hbsn.2018.01.01","article-title":"Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, metabolic syndrome and hepatocellular carcinoma-a composite scenario","volume":"7","author":"Vigano","year":"2018","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"10.1016\/j.yexcr.2019.04.029_bib4","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.3748\/wjg.v24.i19.2083","article-title":"Mediterranean diet and nonalcoholic fatty liver disease","volume":"24","author":"Anania","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.yexcr.2019.04.029_bib5","doi-asserted-by":"crossref","first-page":"H1148","DOI":"10.1152\/ajpheart.00726.2017","article-title":"Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1alpha via downregulation of prolyl hydroxylase 3","volume":"315","author":"Neckar","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yexcr.2019.04.029_bib6","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/HJH.0000000000001708","article-title":"Two pharmacological epoxyeicosatrienoic acid-enhancing therapies are effectively antihypertensive and reduce the severity of ischemic arrhythmias in rats with angiotensin II-dependent hypertension","volume":"36","author":"Cervenka","year":"2018","journal-title":"J. Hypertens."},{"key":"10.1016\/j.yexcr.2019.04.029_bib7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fphar.2014.00216","article-title":"Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury","volume":"5","author":"Khan","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yexcr.2019.04.029_bib8","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/ndt\/gfx354","article-title":"Role of the cytochrome P-450\/epoxyeicosatrienoic acids pathway in the pathogenesis of renal dysfunction in cirrhosis","volume":"33","author":"Yeboah","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.yexcr.2019.04.029_bib9","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fphar.2017.00406","article-title":"Epoxyeicosatrienoic acid analog decreases renal fibrosis by reducing epithelial-to-mesenchymal transition","volume":"8","author":"Skibba","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yexcr.2019.04.029_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/physrev.00021.2011","article-title":"Epoxides and soluble epoxide hydrolase in cardiovascular physiology","volume":"92","author":"Imig","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.yexcr.2019.04.029_bib11","article-title":"Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2019.04.029_bib12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1073\/pnas.1422590112","article-title":"Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides","volume":"112","author":"Lopez-Vicario","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.yexcr.2019.04.029_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.prostaglandins.2016.07.002","article-title":"Characterization of the Cytochrome P450 epoxyeicosanoid pathway in non-alcoholic steatohepatitis","volume":"125","author":"Wells","year":"2016","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.yexcr.2019.04.029_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prostaglandins.2011.10.002","article-title":"Epoxyeicosatrienoic acids and heme oxygenase-1 interaction attenuates diabetes and metabolic syndrome complications","volume":"97","author":"Burgess","year":"2012","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.yexcr.2019.04.029_bib15","doi-asserted-by":"crossref","first-page":"H368","DOI":"10.1152\/ajpheart.00093.2017","article-title":"EET intervention on Wnt1, NOV and HO-1 signaling prevents obesity-induced cardiomyopathy in obese mice","volume":"313","author":"Cao","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yexcr.2019.04.029_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.prostaglandins.2018.05.008","article-title":"EET enhances renal function in obese mice resulting in restoration of HO-1-Mfn1\/2 signaling, and decrease in hypertension through inhibition of sodium chloride co-transporter","volume":"137","author":"Schragenheim","year":"2018","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.yexcr.2019.04.029_bib17","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1089\/scd.2016.0072","article-title":"Epoxyeicosatrienoic acids regulate adipocyte differentiation of mouse 3T3 cells, via PGC-1alpha activation, which is required for HO-1 expression and increased mitochondrial function","volume":"25","author":"Waldman","year":"2016","journal-title":"Stem Cell. Dev."},{"key":"10.1016\/j.yexcr.2019.04.029_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.prostaglandins.2016.07.004","article-title":"PGC-1 alpha regulates HO-1 expression, mitochondrial dynamics and biogenesis: role of epoxyeicosatrienoic acid","volume":"125","author":"Singh","year":"2016","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.yexcr.2019.04.029_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tips.2015.09.003","article-title":"Translational significance of heme oxygenase in obesity and metabolic syndrome","volume":"37","author":"Abraham","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.yexcr.2019.04.029_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1124\/pr.107.07104","article-title":"Pharmacological and clinical aspects of heme oxygenase","volume":"60","author":"Abraham","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.yexcr.2019.04.029_bib21","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1089\/ars.2005.7.1688","article-title":"Molecular basis of heme oxygenase-1 induction: implications for chemoprevention and chemoprotection","volume":"7","author":"Prawan","year":"2005","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.yexcr.2019.04.029_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cmet.2005.03.002","article-title":"Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle","volume":"1","author":"Arany","year":"2005","journal-title":"Cell Metabol."},{"key":"10.1016\/j.yexcr.2019.04.029_bib23","doi-asserted-by":"crossref","first-page":"9635","DOI":"10.1073\/pnas.1207287109","article-title":"Development of insulin resistance in mice lacking PGC-1alpha in adipose tissues","volume":"109","author":"Kleiner","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.yexcr.2019.04.029_bib24","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1074\/jbc.M704332200","article-title":"Modest PGC-1alpha overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria","volume":"283","author":"Benton","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2019.04.029_bib25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fphys.2018.00242","article-title":"Moderate modulation of cardiac PGC-1alpha expression partially affects age-associated transcriptional remodeling of the heart","volume":"9","author":"Whitehead","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.yexcr.2019.04.029_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prostaglandins.2018.07.004","article-title":"Ablation of soluble epoxide hydrolase reprogram white fat to beige-like fat through an increase in mitochondrial integrity, HO-1-adiponectin in vitro and in vivo","volume":"138","author":"Liu","year":"2018","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.yexcr.2019.04.029_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmet.2005.05.004","article-title":"Metabolic control through the PGC-1 family of transcription coactivators","volume":"1","author":"Lin","year":"2005","journal-title":"Cell Metabol."},{"key":"10.1016\/j.yexcr.2019.04.029_bib28","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/hep.29257","article-title":"The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance","volume":"66","author":"Zhang","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.yexcr.2019.04.029_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176873","article-title":"CREG1 heterozygous mice are susceptible to high fat diet-induced obesity and insulin resistance","volume":"12","author":"Tian","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2019.04.029_bib30","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.clinbiochem.2005.01.013","article-title":"Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats","volume":"38","author":"Armutcu","year":"2005","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.yexcr.2019.04.029_bib31","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/j.1572-0241.2004.30159.x","article-title":"Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis","volume":"99","author":"Chalasani","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.yexcr.2019.04.029_bib32","doi-asserted-by":"crossref","first-page":"8713","DOI":"10.3390\/ijms15058713","article-title":"Role of mitochondria in nonalcoholic fatty liver disease","volume":"15","author":"Nassir","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2019.04.029_bib33","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/oby.20559","article-title":"Increased HO-1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21","volume":"22","author":"Hinds","year":"2014","journal-title":"Obesity"},{"key":"10.1016\/j.yexcr.2019.04.029_bib34","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cmet.2015.12.003","article-title":"FGF21 mediates endocrine control of simple sugar intake and sweet taste preference by the liver","volume":"23","author":"von Holstein-Rathlou","year":"2016","journal-title":"Cell Metabol."},{"key":"10.1016\/j.yexcr.2019.04.029_bib35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/physrev.00021.2011","article-title":"Epoxides and soluble epoxide hydrolase in cardiovascular physiology","volume":"92","author":"Imig","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.yexcr.2019.04.029_bib36","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2019.04.029_bib37","doi-asserted-by":"crossref","first-page":"3484107","DOI":"10.1155\/2018\/3484107","article-title":"Development of NASH in obese mice is confounded by adipose tissue increase in inflammatory NOV and oxidative stress","volume":"2018","author":"Sacerdoti","year":"2018","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.yexcr.2019.04.029_bib38","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.2337\/db15-0617","article-title":"NOV\/CCN3: a new adipocytokine involved in obesity-associated insulin resistance","volume":"65","author":"Martinerie","year":"2016","journal-title":"Diabetes"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482719302137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482719302137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:24:44Z","timestamp":1757996684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482719302137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0014482719302137"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2019.04.029","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epoxyeicosatrienoic intervention improves NAFLD in leptin receptor deficient mice by an increase in HO-1-PGC1\u03b1 mitochondrial signaling","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2019.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}